Jump to content

Perioperative Care of the Child with Cancer

From PedsAnesthesiaNet

This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.

Go to the Main Page to see the Topic Outline.

Go to the Generalized Suggested Outline for information on case-specific details for each page.

Go to the Test Page for examples on how to use references in the page.


Relevant Article Depot:


Anesthetic considerations for the pediatric oncology patient--part 1: a review of antitumor therapy

Anesthetic considerations for the pediatric oncology patient--part 2: systems-based approach to anesthesia

Anesthetic considerations for the pediatric oncology patient--part 3: pain, cognitive dysfunction, and preoperative evaluation

Anesthesia Techniques and Long-Term Oncological Outcomes

Anaesthesia after neoadjuvant chemotherapy, immunotherapy or radiotherapy

Factors influencing postoperative morbidity in patients treated with bleomycin

Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?

Bleomycin-induced pneumonitis

Important drug interactions in hematopoietic stem cell transplantation: what every physician should know

Anaesthesia for children with cancer

Russell TB, Kram DE. Tumor lysis syndrome. Pediatr Rev. 2020 Jan; 41(1): 20-26. PMID: 31894070

Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review [published correction appears in J Clin Oncol. 2010 Feb 1; 28(4): 708]. J Clin Oncol. 2008 Jun; 26(16): 2767-2778. PMID: 18509186

Ross FJ, Latham GJ. Perioperative management of the oncology patient. In: Coté CJ, Lerman J, Anderson BJ, eds. A Practice of Anesthesia for Infants and Children. 6th ed. Philadelphia, PA: Elsevier; 2019: 248.

Impact of pediatric anesthesia management on cancer outcomes in children—a narrative review

Perry NJS, Jhanji S, Poulogiannis G. Cancer Biology and the Perioperative Period: Opportunities for Disease Evolution and Challenges for Perioperative Care. Anesthesia and analgesia 2024 (In eng). DOI: 10.1213/ane.0000000000007328.

Stollings LM, Jia LJ, Tang P, Dou H, Lu B, Xu Y. Immune Modulation by Volatile Anesthetics. Anesthesiology 2016;125(2):399-411. (In eng). DOI: 10.1097/aln.0000000000001195.

Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and analgesia 2003;97(5):1331-1339. (In eng). DOI: 10.1213/01.Ane.0000082995.44040.07.

Tazawa K, Koutsogiannaki S, Chamberlain M, Yuki K. The effect of different anesthetics on tumor cytotoxicity by natural killer cells. Toxicol Lett 2017;266:23-31. (In eng). DOI: 10.1016/j.toxlet.2016.12.007.

Plein LM, Rittner HL. Opioids and the immune system - friend or foe. British journal of pharmacology 2018;175(14):2717-2725. (In eng). DOI: 10.1111/bph.13750.

Montagna G, Gupta HV, Hannum M, et al. Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer. British journal of anaesthesia 2021;126(2):367-376. (In eng). DOI: 10.1016/j.bja.2020.10.021.